2025 · 2nd Quarter (Apr 1 - June 30)
Filed by THE NICKLES GROUP, LLC.
Open official filingSource-reported fields
Literal source text
H.R. 1, One Big Beautiful Bill Act and pharmacy benefit management. Issues related to mental health. Issues related to SUPPORT Act Reauthorization. Monitored Pandemic and All-Hazards Preparedness and Response Act (PAHPA) reauthorization. Issues related to pharmacy benefit management, including alternative funding programs. Monitored issues related to healthcare workforce shortages. Issues related to drug pricing. Issues related to ingredient safety.
Literal federal measure citations: H.R. 1
Implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to Ambulatory Surgical Centers. Issues related to pharmacy benefit management. Monitored issues related to Medicare physician payment. H.R. 1, One Big Beautiful Bill Act and issues related to drug pricing. Issues related to Most Favored Nation drug pricing. H.R. 946 / S. 1862, ORPHAN Cures Act.
Literal federal measure citations: H.R. 1, H.R. 946, S. 1862
H.R. 1, One Big Beautiful Bill Act, as it relates to corporate and international taxes.
Literal federal measure citations: H.R. 1
Issues related to litigation reform.
Monitor issues related to tariffs.
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.
